Cardiomyopathy in Friedreich ataxia: clinical findings and research
about
Diagnosis and management of hypertrophic cardiomyopathyTransition of Thalassaemia and Friedreich ataxia from fatal to chronic diseases.Intrathecal delivery of frataxin mRNA encapsulated in lipid nanoparticles to dorsal root ganglia as a potential therapeutic for Friedreich's ataxia.New developments and controversies in iron metabolism and iron chelation therapy.Downregulation of GSTK1 Is a Common Mechanism Underlying Hypertrophic Cardiomyopathy.High-throughput immunoassay for the biochemical diagnosis of Friedreich ataxia in dried blood spots and whole blood.Genetic testing for inherited cardiac disease.Dysregulation of cellular iron metabolism in Friedreich ataxia: from primary iron-sulfur cluster deficit to mitochondrial iron accumulation.Evaluation of genetic causes of cardiomyopathy in childhood.Mitochondrial iron-sulfur cluster biogenesis from molecular understanding to clinical disease.Excision of Expanded GAA Repeats Alleviates the Molecular Phenotype of Friedreich's Ataxia.Lentivirus-meditated frataxin gene delivery reverses genome instability in Friedreich ataxia patient and mouse model fibroblastsIron and copper in mitochondrial diseases.Modeling of Friedreich ataxia-related iron overloading cardiomyopathy using patient-specific-induced pluripotent stem cells.Low apolipoprotein A-I levels in Friedreich's ataxia and in frataxin-deficient cells: Implications for therapy.Neuromuscular diseases with hypertrophic cardiomyopathyValue of cardiac biomarker measurement in the differential diagnosis of infiltrative cardiomyopathy patients with preserved left ventricular systolic function
P2860
Q26773621-A5A5ABC2-D59E-481D-8885-5D806966238BQ34761250-C9A3AA66-6B3C-4FEF-B7C9-4CBB8BAA4CFDQ36588584-341CB127-ED30-4E70-BEDF-72F5D0701C30Q36719376-E19B38A9-1D8D-454F-8CF4-A9C64EAF4CB0Q36999686-DF0AA6B7-3E33-4BF9-AC38-188E2F469849Q37557229-0A301D5E-ECE6-4CC7-A53C-F46971560889Q38125385-71BA9420-FD43-4739-BD11-219EEF3332B0Q38219400-B85AF7F5-9390-44ED-B19F-BC90E0C55750Q38588154-F4EA8B17-B385-4B6D-8822-FC93E8076902Q38773448-F7B9B53A-DAAD-44A2-9645-747752A4CB21Q39786829-981ED5A5-20D8-4E77-BA1D-E07ABFBA2B05Q40533450-EAB1BCD6-C5B2-4B53-B410-8560532E2646Q41260893-05424466-6D6C-46FA-9D46-839EAD2EE8DAQ48806747-77DC36D0-A8B8-45FE-965A-57D694C72147Q49979941-D4B49E6B-6D70-4905-9AB1-BCD357AFFA36Q58565564-647B6522-7CA9-4CC3-8931-AFAFEF638165Q58804421-8446210F-9451-4FA3-BD41-E3D8D091FD30
P2860
Cardiomyopathy in Friedreich ataxia: clinical findings and research
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Cardiomyopathy in Friedreich ataxia: clinical findings and research
@ast
Cardiomyopathy in Friedreich ataxia: clinical findings and research
@en
Cardiomyopathy in Friedreich ataxia: clinical findings and research
@nl
type
label
Cardiomyopathy in Friedreich ataxia: clinical findings and research
@ast
Cardiomyopathy in Friedreich ataxia: clinical findings and research
@en
Cardiomyopathy in Friedreich ataxia: clinical findings and research
@nl
prefLabel
Cardiomyopathy in Friedreich ataxia: clinical findings and research
@ast
Cardiomyopathy in Friedreich ataxia: clinical findings and research
@en
Cardiomyopathy in Friedreich ataxia: clinical findings and research
@nl
P2860
P3181
P356
P1476
Cardiomyopathy in Friedreich ataxia: clinical findings and research
@en
P2093
G. R. Wagner
R. M. Payne
P2860
P304
P3181
P356
10.1177/0883073812448535
P407
P577
2012-09-01T00:00:00Z